Article
Signal Transduction–Directed Cancer Treatments
22 Jan 2003
Abstract excerpt
The pathogenic mechanisms giving rise to cancer frequently involve altered signal transduction pathways. Therefore therapeutic agents that directly address signal transduction molecules are being explored as cancer treatments. Inhibitors of protein tyrosine and threonine kinases including STI-571, ZD-1839, OSI-774, and flavopiridol are ATP-site antagonists that have completed initial phase I and phase II...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
